New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202300340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Mohammad Mahboob Alam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Cyclooxygenase 2 Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: This work was supported by a funded grant from the Institutional Fund Projects, Ministry of Education in Saudi Arabia.
Abstract (Originalsprache)
Drug repurposing is an emerging field in drug development that has provided many successful drugs. In the current study, paracetamol, a known antipyretic and analgesic agent, was chemically modified to generate paracetamol derivatives as anticancer and anticyclooxygenase‐2 (COX‐2) agents. Compound 11 bearing a fluoro group was the best cytotoxic candidate with half‐maximal inhibitory concentration (IC 50 ) values ranging from 1.51 to 6.31 μM and anti‐COX‐2 activity with IC 50 = 0.29 μM, compared to the standard drugs, doxorubicin and celecoxib. The cell cycle and apoptosis studies revealed that compound 11 possesses the ability to induce cell cycle arrest in the S phase and apoptosis in colon Huh‐7 cells. These results were strongly supported by docking studies, which showed strong interactions with the amino acids of the COX‐2 protein, and in silico pharmacokinetic predictions were found to be favorable for these newly synthesized paracetamol derivatives. It can be concluded that compound 11 could block cell growth and proliferation by inhibiting the COX‐2 enzyme in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia.
- Department of Chemistry, Faculty of Science, Sohag University, Sohag, Egypt.
- Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Department of Health Information Technology, Faculty of Applied Studies, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt.
Förderung
- This work was supported by a funded grant from the Institutional Fund Projects, Ministry of Education in Saudi Arabia
Zitieren
APA
Alam, M. M., Alsenani, N. I., Abdelhamid, A. A., Ahmad, A., Baothman, O. A., Hosawi, S. A., Altayeb, H., Nadeem, M. S., Ahmad, V., Nazreen, S., & Elhenawy, A. A. (2024). New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300340
Vancouver
Alam MM, Alsenani NI, Abdelhamid AA, Ahmad A, Baothman OA, Hosawi SA, et al. New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300340
BibTeX
@article{Alam2024,
author = {Alam, Mohammad Mahboob and Alsenani, Nawaf I and Abdelhamid, Antar A and Ahmad, Abrar and Baothman, Othman A and Hosawi, Salman A and Altayeb, Hisham and Nadeem, Mohammad Shahid and Ahmad, Varish and Nazreen, Syed and Elhenawy, Ahmed A},
title = {New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202300340}
}
EUVIMED